PERRIGO Co plc PRGO
PRGO among the 162 companies we cover
Where it stands · the better end on the right. The band holds the middle half; the line is the median.
PRGO and 9 peers, year by year
The 9 Health care companies closest to PRGO in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.
Choose the peers
| Company | Year | Revenue | Sales growth | Gross margin | Operating margin | Net margin | FCF margin | Return on equity | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|
| PRGO PERRIGO Co plc | FY2025 | $4.3B | −2.8% | 35.1% | −26.4% | −33.5% | 3.4% | −48.6% | 1.24 |
| ALGN Align Technology | FY2025 | $4.0B | +0.9% | 67.2% | 13.5% | 10.2% | 12.2% | 10.1% | - |
| MTD Mettler Toledo | FY2025 | $4.0B | +4.0% | 59.4% | - | 21.6% | 21.1% | n/m | n/m |
| CRL Charles River Laboratories | FY2025 | $4.0B | −0.9% | - | 0.6% | −3.6% | 12.9% | −4.6% | 0.68 |
| COO Cooper Companies | FY2025 | $4.1B | +5.1% | 65.5% | 16.7% | 9.2% | 10.6% | 4.6% | 0.30 |
| NBIX Neurocrine Biosciences Inc | FY2025 | $2.9B | +21.4% | - | 21.6% | 16.7% | 26.2% | 14.7% | - |
| BMRN Biomarin Pharmaceutical Inc | FY2025 | $3.2B | +12.9% | - | 12.7% | 10.8% | 22.5% | 5.7% | 0.10 |
| ILMN Illumina, Inc. | FY2025 | $4.3B | −0.7% | 66.1% | 18.6% | 19.6% | 21.4% | 31.2% | 0.73 |
| XRAY DENTSPLY SIRONA Inc. | FY2025 | $3.7B | −3.0% | 50.0% | −11.5% | −16.2% | 2.8% | −44.7% | 1.76 |
| IDXX Idexx Laboratories | FY2025 | $4.3B | +10.4% | 61.8% | 31.6% | 24.6% | 24.6% | 66.0% | 0.28 |
Each company, year by year
Bars: revenue, each company on its own scale. Line: net margin, on one scale for all. FY2016 to FY2025 · 10-K XBRL
Who rewrote the most
Share of the words changed in Risk Factors and in MD&A, latest 10-K against the one before
Revenue, FY2016 to FY2025
Revenue as reported in the 10-K.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| PRGO Dec | $5.3B | $4.9B | $4.7B | $3.9B | $4.1B | $4.1B | $4.5B | $4.7B | $4.4B | $4.3B |
| ALGN Dec | $1.1B | $1.5B | $2.0B | $2.4B | $2.5B | $4.0B | $3.7B | $3.9B | $4.0B | $4.0B |
| MTD Dec | $2.5B | $2.7B | $2.9B | $3.0B | $3.1B | $3.7B | $3.9B | $3.8B | $3.9B | $4.0B |
| CRL Dec | $1.7B | $1.9B | $2.3B | $2.6B | $2.9B | $3.5B | $4.0B | $4.1B | $4.0B | $4.0B |
| COO Oct | $2.0B | $2.1B | $2.5B | $2.7B | $2.4B | $2.9B | $3.3B | $3.6B | $3.9B | $4.1B |
| NBIX Dec | $15.0M | $161.6M | $451.2M | $788.1M | $1.0B | $1.1B | $1.5B | $1.9B | $2.4B | $2.9B |
| BMRN Dec | $1.1B | $1.3B | $1.5B | $1.7B | $1.9B | $1.8B | $2.1B | $2.4B | $2.9B | $3.2B |
| ILMN Dec | $2.4B | $2.8B | $3.3B | $3.5B | $3.2B | $4.5B | $4.6B | $4.5B | $4.4B | $4.3B |
| XRAY Dec | $3.7B | $4.0B | $4.0B | $4.0B | $3.3B | $4.2B | $3.9B | $4.0B | $3.8B | $3.7B |
| IDXX Dec | $1.8B | $2.0B | $2.2B | $2.4B | $2.7B | $3.2B | $3.4B | $3.7B | $3.9B | $4.3B |
| Peer median | $1.8B | $2.0B | $2.3B | $2.6B | $2.7B | $3.5B | $3.7B | $3.8B | $3.9B | $4.0B |
Sales growth, FY2016 to FY2025
Revenue against the fiscal year before.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| PRGO Dec | - | −6.3% | −4.3% | +2.2% | +5.6% | +1.2% | +7.6% | +4.6% | −6.1% | −2.8% |
| ALGN Dec | +27.7% | +36.4% | +33.5% | +22.4% | +2.7% | +59.9% | −5.5% | +3.4% | +3.5% | +0.9% |
| MTD Dec | +4.7% | +8.6% | +7.7% | +2.5% | +2.5% | +20.5% | +5.4% | −3.4% | +2.2% | +4.0% |
| CRL Dec | +23.3% | +10.5% | +22.0% | +15.7% | +11.5% | +21.1% | +12.3% | +3.9% | −1.9% | −0.9% |
| COO Oct | +9.4% | +8.8% | +18.4% | +4.8% | −8.4% | +20.2% | +13.2% | +8.6% | +8.4% | +5.1% |
| NBIX Dec | −24.1% | +978% | +179% | +74.7% | +32.7% | +8.4% | +31.3% | +26.8% | +24.8% | +21.4% |
| BMRN Dec | +25.5% | +17.6% | +13.5% | +14.3% | +9.2% | −0.8% | +13.5% | +15.4% | +18.0% | +12.9% |
| ILMN Dec | +8.0% | +14.8% | +21.1% | +6.3% | −8.6% | +39.7% | +1.3% | −1.7% | −2.9% | −0.7% |
| XRAY Dec | +40.0% | +6.6% | −0.2% | +1.1% | −17.0% | +26.7% | −7.3% | +1.1% | −4.3% | −3.0% |
| IDXX Dec | +10.8% | +10.9% | +12.4% | +8.8% | +12.5% | +18.8% | +4.7% | +8.7% | +6.5% | +10.4% |
| Peer median | +10.8% | +10.9% | +18.4% | +8.8% | +2.7% | +20.5% | +5.4% | +3.9% | +3.5% | +4.0% |
Gross margin, FY2016 to FY2025
Gross profit / revenue.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| PRGO Dec | 38.9% | 40.0% | 38.7% | 37.0% | 36.6% | 34.2% | 32.7% | 36.1% | 35.3% | 35.1% |
| ALGN Dec | 75.5% | 75.8% | 73.6% | 72.5% | 71.3% | 74.3% | 70.5% | 70.1% | 70.0% | 67.2% |
| MTD Dec | 57.3% | 57.8% | 57.4% | 57.9% | 58.4% | 58.4% | 58.9% | 59.2% | 60.1% | 59.4% |
| CRL Dec | - | - | - | - | - | - | - | - | - | - |
| COO Oct | 59.6% | 63.9% | 64.4% | 66.2% | 63.1% | 66.9% | 64.7% | 65.6% | 66.6% | 65.5% |
| NBIX Dec | - | - | - | - | - | - | - | - | - | - |
| BMRN Dec | - | - | - | - | - | - | - | - | - | - |
| ILMN Dec | 69.5% | 66.4% | 69.0% | 69.6% | 68.0% | 69.7% | 64.8% | 60.9% | 65.4% | 66.1% |
| XRAY Dec | 53.4% | 54.8% | 51.9% | 53.8% | 49.6% | 55.5% | 54.2% | 52.6% | 51.6% | 50.0% |
| IDXX Dec | 54.9% | 55.7% | 56.1% | 56.7% | 58.0% | 58.8% | 59.5% | 59.8% | 61.0% | 61.8% |
| Peer median | 58.5% | 60.8% | 60.9% | 62.0% | 60.8% | 62.8% | 62.1% | 60.4% | 63.2% | 63.7% |
Operating margin, FY2016 to FY2025
Operating income / revenue.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| PRGO Dec | −37.9% | 12.1% | 5.0% | 4.5% | 6.5% | 9.9% | 1.8% | 3.3% | 2.6% | −26.4% |
| ALGN Dec | 23.1% | 24.0% | 23.7% | 22.5% | 15.7% | 24.7% | 17.2% | 16.7% | 15.2% | 13.5% |
| MTD Dec | - | - | - | - | - | - | - | - | - | - |
| CRL Dec | 14.1% | 15.5% | 14.6% | 13.4% | 14.8% | 16.7% | 16.4% | 14.9% | 5.6% | 0.6% |
| COO Oct | 16.5% | 20.1% | 15.9% | 20.6% | 12.8% | 17.3% | 15.3% | 14.8% | 18.1% | 16.7% |
| NBIX Dec | −982.5% | −81.3% | 8.2% | 9.2% | 15.6% | 9.0% | 16.7% | 13.3% | 24.2% | 21.6% |
| BMRN Dec | −71.9% | −1.1% | −8.3% | −5.9% | −2.3% | −4.5% | 7.7% | 7.7% | 17.0% | 12.7% |
| ILMN Dec | 24.5% | 22.0% | 26.5% | 27.8% | 17.9% | −2.7% | −91.2% | −23.7% | −19.1% | 18.6% |
| XRAY Dec | 12.1% | −39.1% | −24.0% | 8.8% | −0.1% | 14.4% | −23.9% | −2.1% | −23.2% | −11.5% |
| IDXX Dec | 19.7% | 21.0% | 22.2% | 23.0% | 25.7% | 29.0% | 26.7% | 30.0% | 29.0% | 31.6% |
| Peer median | 15.3% | 17.8% | 15.3% | 17.0% | 15.2% | 15.5% | 15.9% | 14.1% | 16.1% | 15.1% |
Net margin, FY2016 to FY2025
Net income / revenue.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| PRGO Dec | −76.0% | 2.4% | 2.8% | 3.8% | −4.0% | −1.7% | −3.2% | −0.3% | −3.9% | −33.5% |
| ALGN Dec | 17.6% | 15.7% | 20.4% | 18.4% | 71.8% | 19.5% | 9.7% | 11.5% | 10.5% | 10.2% |
| MTD Dec | 15.3% | 13.8% | 17.5% | 18.6% | 19.5% | 20.7% | 22.3% | 20.8% | 22.3% | 21.6% |
| CRL Dec | 9.2% | 6.6% | 10.0% | 9.6% | 12.5% | 11.0% | 12.2% | 11.5% | 0.5% | −3.6% |
| COO Oct | 13.9% | 17.4% | 5.5% | 17.6% | 9.8% | 100.8% | 11.7% | 8.2% | 10.1% | 9.2% |
| NBIX Dec | −940.6% | −88.2% | 4.7% | 4.7% | 38.9% | 7.9% | 10.4% | 13.2% | 14.5% | 16.7% |
| BMRN Dec | −56.4% | −8.9% | −5.2% | −1.4% | 45.9% | −3.5% | 6.8% | 6.9% | 15.0% | 10.8% |
| ILMN Dec | 19.3% | 26.4% | 24.8% | 28.3% | 20.3% | 16.8% | −96.1% | −25.8% | −28.0% | 19.6% |
| XRAY Dec | 11.5% | −38.8% | −25.4% | 6.4% | −2.2% | 9.7% | −24.2% | −3.3% | −24.0% | −16.2% |
| IDXX Dec | 12.5% | 13.4% | 17.0% | 17.8% | 21.5% | 23.2% | 20.2% | 23.1% | 22.8% | 24.6% |
| Peer median | 12.5% | 13.4% | 10.0% | 17.6% | 20.3% | 16.8% | 10.4% | 11.5% | 10.5% | 10.8% |
Free cash flow, FY2016 to FY2025
Cash from operations minus capital spending.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| PRGO Dec | $548.7M | $610.3M | $490.4M | $250.1M | $465.8M | $4.2M | $210.9M | $303.8M | $244.6M | $145.1M |
| ALGN Dec | $177.1M | $242.8M | $331.4M | $597.6M | $507.3M | $771.4M | $276.8M | $608.1M | $622.7M | $490.8M |
| MTD Dec | $336.8M | $388.9M | $422.3M | $506.1M | $632.2M | $801.2M | $737.8M | $860.6M | $864.4M | $848.6M |
| CRL Dec | $261.6M | $235.6M | $301.1M | $340.4M | $380.0M | $532.0M | $294.9M | $365.4M | $501.6M | $518.5M |
| COO Oct | $357.0M | $466.4M | $475.3M | $421.1M | $176.2M | $524.2M | $450.4M | $215.0M | $288.1M | $433.7M |
| NBIX Dec | −$110.3M | −$101.3M | $76.6M | $132.3M | $217.6M | $233.1M | $322.9M | $361.6M | $557.2M | $748.7M |
| BMRN Dec | −$376.2M | −$208.0M | −$124.4M | −$96.8M | −$28.9M | $209.0M | $54.9M | $62.6M | $487.4M | $725.0M |
| ILMN Dec | $519.0M | $565.0M | $846.0M | $842.0M | $891.0M | $337.0M | $106.0M | $283.0M | $709.0M | $931.0M |
| XRAY Dec | $438.4M | $457.6M | $317.0M | $516.0M | $562.0M | $515.0M | $368.0M | $228.0M | $281.0M | $104.0M |
| IDXX Dec | $274.2M | $298.9M | $284.3M | $304.2M | $541.1M | $636.0M | $394.1M | $772.9M | $808.1M | $1.1B |
| Peer median | $274.2M | $298.9M | $317.0M | $421.1M | $507.3M | $524.2M | $322.9M | $361.6M | $557.2M | $725.0M |
FCF margin, FY2016 to FY2025
Free cash flow / revenue.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| PRGO Dec | 10.4% | 12.3% | 10.4% | 6.5% | 11.4% | 0.1% | 4.7% | 6.5% | 5.6% | 3.4% |
| ALGN Dec | 16.4% | 16.5% | 16.9% | 24.8% | 20.5% | 19.5% | 7.4% | 15.7% | 15.6% | 12.2% |
| MTD Dec | 13.4% | 14.3% | 14.4% | 16.8% | 20.5% | 21.6% | 18.8% | 22.7% | 22.3% | 21.1% |
| CRL Dec | 15.6% | 12.7% | 13.3% | 13.0% | 13.0% | 15.0% | 7.4% | 8.8% | 12.4% | 12.9% |
| COO Oct | 18.2% | 21.8% | 18.8% | 15.9% | 7.2% | 17.9% | 13.6% | 6.0% | 7.4% | 10.6% |
| NBIX Dec | −735.3% | −62.7% | 17.0% | 16.8% | 20.8% | 20.6% | 21.7% | 19.2% | 23.7% | 26.2% |
| BMRN Dec | −33.7% | −15.8% | −8.3% | −5.7% | −1.6% | 11.3% | 2.6% | 2.6% | 17.1% | 22.5% |
| ILMN Dec | 21.6% | 20.5% | 25.4% | 23.8% | 27.5% | 7.4% | 2.3% | 6.3% | 16.2% | 21.4% |
| XRAY Dec | 11.7% | 11.5% | 8.0% | 12.8% | 16.8% | 12.2% | 9.4% | 5.8% | 7.4% | 2.8% |
| IDXX Dec | 15.4% | 15.2% | 12.8% | 12.6% | 20.0% | 19.8% | 11.7% | 21.1% | 20.7% | 24.6% |
| Peer median | 15.4% | 14.3% | 14.4% | 15.9% | 20.0% | 17.9% | 9.4% | 8.8% | 16.2% | 21.1% |
Return on equity, FY2016 to FY2025
Net income / shareholders' equity at the year end.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| PRGO Dec | −67.4% | 1.9% | 2.3% | 2.5% | −2.9% | −1.3% | −2.9% | −0.3% | −4.0% | −48.6% |
| ALGN Dec | 19.0% | 20.0% | 31.9% | 32.9% | 54.9% | 21.3% | 10.0% | 12.3% | 10.9% | 10.1% |
| MTD Dec | 88.4% | 68.7% | 86.9% | 133.3% | n/m | n/m | n/m | n/m | n/m | n/m |
| CRL Dec | 18.5% | 11.8% | 17.2% | 15.4% | 17.2% | 15.4% | 16.3% | 13.2% | 0.6% | −4.6% |
| COO Oct | 10.2% | 11.7% | 4.2% | 12.9% | 6.2% | 42.4% | 5.4% | 3.9% | 4.9% | 4.6% |
| NBIX Dec | −44.8% | −38.3% | 4.4% | 5.8% | 36.2% | 6.5% | 9.0% | 11.2% | 13.2% | 14.7% |
| BMRN Dec | −22.8% | −4.2% | −2.6% | −0.8% | 20.8% | −1.5% | 3.1% | 3.4% | 7.5% | 5.7% |
| ILMN Dec | 21.1% | 26.4% | 22.0% | 21.7% | 14.0% | 7.1% | −66.7% | −20.2% | −51.5% | 31.2% |
| XRAY Dec | 5.3% | −23.4% | −19.7% | 5.0% | −1.5% | 8.2% | −24.9% | −4.0% | −46.9% | −44.7% |
| IDXX Dec | n/m | n/m | n/m | n/m | 92.0% | 107.9% | 111.6% | 56.9% | 55.7% | 66.0% |
| Peer median | 14.3% | 11.8% | 10.8% | 14.1% | 19.0% | 11.8% | 7.2% | 7.5% | 6.2% | 7.9% |
Debt / equity, FY2016 to FY2025
Total debt / shareholders' equity at the year end.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| PRGO Dec | 0.97 | 0.54 | 0.57 | 0.58 | 0.63 | 0.68 | 0.85 | 0.85 | 0.84 | 1.24 |
| ALGN Dec | - | - | - | - | - | - | - | - | - | - |
| MTD Dec | 2.06 | 1.79 | 1.75 | 3.07 | 4.72 | 9.81 | n/m | n/m | n/m | n/m |
| CRL Dec | 1.41 | 1.04 | 1.22 | 1.15 | 0.93 | 1.05 | 0.91 | 0.74 | 0.65 | 0.68 |
| COO Oct | 0.57 | 0.37 | 0.61 | 0.50 | 0.47 | 0.21 | 0.38 | 0.34 | 0.32 | 0.30 |
| NBIX Dec | - | - | - | - | - | - | - | - | - | - |
| BMRN Dec | - | - | - | - | - | - | - | - | - | 0.10 |
| ILMN Dec | 0.48 | 0.43 | 0.22 | 0.25 | 0.25 | 0.09 | 0.30 | 0.26 | 0.84 | 0.73 |
| XRAY Dec | 0.19 | 0.25 | 0.32 | 0.28 | 0.46 | 0.42 | 0.52 | 0.65 | 1.12 | 1.76 |
| IDXX Dec | n/m | n/m | n/m | 3.94 | 1.44 | 1.23 | 1.26 | 0.47 | 0.39 | 0.28 |
| Peer median | 0.57 | 0.43 | 0.61 | 0.83 | 0.70 | 0.74 | 0.52 | 0.47 | 0.65 | 0.49 |
EPS (diluted), FY2016 to FY2025
Diluted earnings per share, on today's share count after splits.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| PRGO Dec | −$28.01 | $0.84 | $0.95 | $1.07 | −$1.19 | −$0.52 | −$1.04 | −$0.09 | −$1.25 | −$10.29 |
| ALGN Dec | $2.33 | $2.83 | $4.92 | $5.53 | $22.41 | $9.69 | $4.61 | $5.81 | $5.62 | $5.65 |
| MTD Dec | $14.22 | $14.24 | $19.88 | $22.47 | $24.91 | $32.78 | $38.41 | $35.90 | $40.48 | $42.05 |
| CRL Dec | $3.23 | $2.54 | $4.62 | $5.07 | $7.20 | $7.60 | $9.48 | $9.22 | $0.20 | −$2.91 |
| COO Oct | $1.40 | $1.88 | $0.70 | $2.33 | $1.20 | $14.79 | $1.94 | $1.48 | $1.96 | $1.87 |
| NBIX Dec | −$1.63 | −$1.62 | $0.22 | $0.39 | $4.16 | $0.92 | $1.56 | $2.47 | $3.29 | $4.67 |
| BMRN Dec | −$3.81 | −$0.67 | −$0.44 | −$0.13 | $4.50 | −$0.35 | $0.75 | $0.87 | $2.21 | $1.80 |
| ILMN Dec | $3.07 | $4.92 | $5.56 | $6.74 | $4.45 | $5.04 | −$28.00 | −$7.34 | −$7.69 | $5.45 |
| XRAY Dec | $1.94 | −$6.76 | −$4.51 | $1.14 | −$0.33 | $1.87 | −$4.41 | −$0.62 | −$4.48 | −$3.00 |
| IDXX Dec | $2.44 | $2.94 | $4.26 | $4.89 | $6.71 | $8.60 | $8.03 | $10.06 | $10.67 | $13.08 |
| Peer median | $2.33 | $2.54 | $4.26 | $4.89 | $4.50 | $7.60 | $1.94 | $2.47 | $2.21 | $4.67 |
Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out PRGO and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more
Sources
Each company's 10-K, from SEC's XBRL company facts. Every number links to its filing in the Inline XBRL viewer.
Also
Financials: PRGO's own statements, year by year. Compare: the whole peer group on one page.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PRGO/export.csv") into a cell.